Jp. Herault et al., COMPARATIVE EFFECTS OF 2 DIRECT AND INDIRECT FACTOR XA INHIBITORS ON FREE AND CLOT-BOUND PROTHROMBINASE, The Journal of pharmacology and experimental therapeutics, 283(1), 1997, pp. 16-22
Factor Xa, as with thrombin, binds to the clot and contributes to the
propensity of thrombi to activate the coagulation system. The aim of t
his work was to compare the extent of prothrambinase inhibition produc
ed by two factor Xa inhibitors: the antithrombin III-dependent synthet
ic pentasaccharide (SR 90107/Org 31540) and DX-9065A, a direct factor
Xa inhibitor. When incubated together with prothrombin, factor Xa, pho
spholipids, antithrombin III and calcium, clots formed from human plas
ma exhibited a prothrombinase activity as measured through fragment 1-
2 (F1+2) generation. Ten washes of the clot were required to achieve c
omplete removal of unbound factor Xa. The absence of F1+2, generation
brought about by washed clots in buffer when factor V was omitted, or
in the presence of annexin V, indicated that they contained bound fact
or Xa and phospholipids but no factor V/Va. in all tested experimental
conditions, clot-bound-factor Xa-induced F1+2 generation was inhibite
d by SR 90107/AT and DX-9065A with IC50 in the same range of concentra
tions (0.5 mu M). In contrast, the inhibition of prothrombinase formed
with factor Xa, factor Va phospholipids and calcium in buffer was obs
erved at significantly lower concentrations of DX-9065A than of SR 901
07/AT (respective IC50 concentrations: 0.1 and 70 mu M), In vivo, fibr
in accretion onto a preformed thrombus as well as venous thrombosis in
duced in the jugular vein of rabbits was inhibited by SR 90107 and DX-
9065A in the same range of concentrations therefore showing that inhib
ition of clot-bound factor Xa is a predominant factor for the antithro
mbotic activity of both direct and indirect inhibitors for factor Xa.